NOTV Stock Analysis: Buy, Sell, or Hold?
NOTV - Inotiv, Inc. Common Stock
$0.26
-0.01 (-4.40%)
▼
5d:
-13.8%
30d:
-8.37%
90d:
-52.33%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When NOTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NOTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NOTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NOTV is currently trading at $0.26, which is considered oversold relative to its 30-day fair value range of $0.27 to $0.38.
Technical Outlook: Technically, NOTV is in a strong downtrend. Immediate support is located at $0.24, while resistance sits at $0.39. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: NOTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+1147.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NOTV is in a strong downtrend. Immediate support is located at $0.24, while resistance sits at $0.39. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: NOTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+1147.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.27 -
$0.38
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 1147.6% below Wall St target ($3.25)
- CAUTION: 5-day price weakness (-13.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.27 -
$0.38
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.24
Resistance Level
$0.39
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.14
Wall Street Target
$3.25
(+1147.6%)
Revenue Growth (YoY)
0.8%
Profit Margin
-13.5%
Share & Embed Analysis
Last updated: April 02, 2026 4:18 AM ET
Data refreshes hourly during market hours. Next update: 5:18 AM
Data refreshes hourly during market hours. Next update: 5:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NOTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Beth A Taylor
SELL
2888 shares
2026-02-17
John E Sagartz
SELL
2119 shares
2026-02-17
Robert Jr. Leasure
SELL
16810 shares
2026-02-17
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 66 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 62 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 66 BUY |
